MedTrace Logo

Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock

NCT06572995 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-08-27

No results posted yet for this study

Summary

In ICU, fluid challenge represents one of the cornerstones of hemodynamic care. However, fluid overload due to an excessive and/or inappropriate fluid administration could be associated with morbidity or mortality. Unfortunately, there is currently no continuous non-invasive devices to monitor fluid content at bedside. Bio reactance is a non-invasive, rapid and continuous technology developed in order to measure body fluid compartment. Monitoring devices functioning with such technology are promising to evaluate fluid overload in ICU.

Conditions

  • Sepsis
  • Septic Shock
  • Hemodynamic Instability
  • Fluid Overload

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Xavier Chapalain, MD · University Hospital, Brest

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2025-06-01
Completion
2025-06-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06572995 on ClinicalTrials.gov